Sustainability | January 07, 2026
WuXi Biologics secures ISO 20400 certification
WuXi Biologics has integrated sustainability principles throughout its supplier lifecycle management
WuXi Biologics has integrated sustainability principles throughout its supplier lifecycle management
Rajdeep is an accomplished business leader with a strong techno-commercial background in the healthcare and diagnostic sector
Under the agreement, Insilico could receive up to $32 million in upfront and near-term R&D payments
The decision positions Yartemlea as the first and only approved inhibitor of the lectin pathway of complement
The FDA acknowledged that Corcept’s pivotal GRACE trial met its primary endpoint and that data from the GRADIENT trial offered confirmatory evidence
The Phase II study will assess the safety, tolerability, pharmacokinetics, and preliminary efficacy of 9MW3811 in patients with pathological scarring
Dr. Chand held several leadership positions within AstraZeneca and the broader biopharmaceutical industry
His professional background also includes key experience at Matrix Labs and Sun Pharma
The filing clears the regulatory path for potential first-in-human trials and marks a key advance in the company’s chronic inflammatory disease pipeline
The approval is supported by data from three pivotal clinical trials
Subscribe To Our Newsletter & Stay Updated
